Word

O

Status

Dead

Status Code

710

Status Date

Friday, July 24, 2015

Serial Number

76444457

Registration Number

2912020

Registration Date

Tuesday, December 21, 2004

Mark Type

3000

Filing Date

Wednesday, August 28, 2002

Published for Opposition

Tuesday, September 28, 2004

Cancellation Date

Friday, July 24, 2015

Trademark Owner History

MICROMET AG - Original Registrant

Classifications

1 [Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives, all for scientific research purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Flourescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes ]

5 [ Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases, preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use; eukaryotic cells, eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture, and of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Fluorescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; sanitary preparations for medical purposes, namely, pharmaceutical agents for dental care ]

9 [ Diagnostic and testing apparatus, systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Fluorescence Activated Cell Sorting FACS devices, lasers, balloon instruments, magnetic devices, all for scientific research purposes, development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides ]

10 [ Diagnostic and testing apparatus, systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting devices FACS, lasers, balloon instruments, magnetic devices, all for clinical medical purposes, clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material ]

42 Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses of animal and human diseases for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

The stippling is a feature of the mark and does not indicate color.

Trademark Events

Jul 24, 2015

Cancelled Sec. 8 (10-Yr)/Expired Section 9

Aug 1, 2011

Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed

Aug 1, 2011

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Jun 20, 2011

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

Aug 1, 2011

Case Assigned To Post Registration Paralegal

Jun 20, 2011

Teas Section 8 & 15 Received

Nov 24, 2010

Attorney Revoked And/Or Appointed

Nov 24, 2010

Teas Revoke/Appoint Attorney Received

Oct 2, 2005

Teas Change Of Correspondence Received

Jul 20, 2005

Teas Change Of Correspondence Received

Dec 21, 2004

Registered-Principal Register

Sep 28, 2004

Published For Opposition

Sep 8, 2004

Notice Of Publication

Jul 15, 2004

Approved For Pub - Principal Register

May 25, 2004

Correspondence Received In Law Office

May 25, 2004

Correspondence Received In Law Office

May 25, 2004

Paper Received

May 3, 2004

Correspondence Received In Law Office

May 3, 2004

Paper Received

Nov 17, 2003

Unresponsive/Duplicate Paper Received

Nov 17, 2003

Paper Received

Dec 1, 2003

Final Refusal Mailed

Oct 7, 2003

Correspondence Received In Law Office

Oct 10, 2003

Correspondence Received In Law Office

Oct 10, 2003

Paper Received

Sep 15, 2003

Non-Final Action Mailed

Jun 23, 2003

Correspondence Received In Law Office

Aug 5, 2003

Case File In Ticrs

Jun 23, 2003

Paper Received

May 16, 2003

Correspondence Received In Law Office

May 16, 2003

Paper Received

Dec 10, 2002

Non-Final Action Mailed

Nov 18, 2002

Assigned To Examiner